CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Pharmaxis Ltd Company Snapshot
Pharmaxis Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pharmaxis Ltd with three other companies in this sector in Australia: Idt Australia Limited. (2016 sales of 16.91 million Australian Dollars [US$12.89 million] of which 55% was CMAX), Xrf Scientific Ltd (21.13 million Australian Dollars [US$16.11 million] of which 43% was Precious Metals), and Anteo Diagnostics Limited (12.67 million Australian Dollars [US$9.66 million] ).

Sales Analysis. Sales fell dramatically in 2016: During the year ended June of 2016, sales at Pharmaxis Ltd were A$18.57 million (US$14.16 million). This is a sharp decrease of 68.3% versus 2015, when the company's sales were A$58.63 million. Contributing to the drop in overall sales was the 93.6% decline in New Drug Development, from A$40.60 million to A$2.58 million. There were also decreases in sales in Bronchitol and Aridol (down 15.0% to A$14.91 million) and Corporate (down 17.0% to A$317,000.00 ) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Pharmaxis Ltd
  Stock Performance Chart for Pharmaxis Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): .26
(Figures in Australian Dollars)
1 Week -3.7%   13 Weeks -8.8%  
4 Weeks -3.7%   52 Weeks 6.1%  
 
Pharmaxis Ltd Key Data:
  Ticker: PXS Country: Australia
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 18,573,000
(Year Ending Jan 2017).
Employees: 107
  Currency: Australian Dollars Market Cap: 82,863,779
  Fiscal Yr Ends: June Shares Outstanding: 318,706,844
  Share Type: Ordinary Closely Held Shares: 45,892,109
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.